Oral Bioavailability of Metronidazole
Metronidazole has excellent oral bioavailability of approximately 99% (98.9%), making it nearly completely absorbed from the gastrointestinal tract 1, 2.
Pharmacokinetic Details
The FDA drug label confirms that metronidazole is well absorbed following oral administration, with peak plasma concentrations occurring between 1-2 hours after dosing 1. This high bioavailability means that oral and intravenous formulations produce essentially equivalent systemic exposure.
Key Pharmacokinetic Parameters:
- Bioavailability: 98.9% (essentially complete absorption) 2
- Time to peak concentration: 1-2 hours 1
- Dose-proportional plasma levels:
- 250 mg oral → 6 mcg/mL peak
- 500 mg oral → 12 mcg/mL peak
- 2,000 mg oral → 40 mcg/mL peak 1
Clinical Implications:
The disposition of metronidazole in the body is similar for both oral and intravenous dosage forms 1. This near-complete oral bioavailability has important practical implications:
- Oral metronidazole should be strongly preferred over IV when the patient can take oral medications, as it achieves equivalent therapeutic concentrations at substantially lower cost 3
- The systemic oral bioavailability is approximately 1.0 (100%) for both low (0.5 g) and high (2.0 g) doses 4
- No gender-based differences in bioavailability exist, though males may have slightly lower plasma levels due to weight differences 1
Factors NOT Affecting Bioavailability:
The only condition requiring dosage adjustment is hepatic impairment, which decreases metronidazole clearance but does not affect absorption 1, 5.
Alternative Routes:
When oral administration is contraindicated:
Given the excellent and reliable oral bioavailability, IV metronidazole should be reserved exclusively for patients who are nil-by-mouth or have contraindications to oral/rectal administration 3.